No the last thing they need is a CR , it will just piss of existing shareholders and crash the SP before they can even get it up . The directors NEED to cut deals to partner one or more products preferably with a major US company that has clout in the FDA . This would hopefully give AHZ a large cash injection and leave the cost of further. development of the project in someone else’s hands . The directors need to do what they are paid to do , so far they have done a crap job and keep on diluting everyone’s shareholding while continuing R@D on to many products without achieving the approvals or sales needed to maintain the companies capital base . The directors need to man up and fix the mess they created
- Forums
- ASX - By Stock
- AVR
- News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-148
-
- There are more pages in this discussion • 420 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.30 |
Change
-0.650(5.44%) |
Mkt cap ! $238.8M |
Open | High | Low | Value | Volume |
$11.71 | $11.83 | $11.24 | $346.8K | 29.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 90 | $11.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 50 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 90 | 11.050 |
2 | 228 | 11.000 |
1 | 25 | 10.990 |
1 | 500 | 10.960 |
1 | 1000 | 10.820 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 50 | 1 |
11.800 | 200 | 1 |
12.000 | 5023 | 2 |
12.010 | 191 | 1 |
12.020 | 1000 | 1 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |